BrainStorm Cell Therapeutics
Total Awards:
1
Award Value:
$15,912,390
Institution type:
For profit
Short Name:
BrainStorm
Awards to the Institution
| Program | Investigator | Award Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Ralph Kern | A Phase 3, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy & Safety of Repeated Administrations of NurOwn® in Patients with ALS | $15,912,390 |
Total: $15,912,390.00 |
